Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 5
2006 2
2007 2
2008 2
2009 1
2010 4
2011 2
2012 2
2013 1
2014 4
2015 4
2016 5
2018 2
2019 2
2020 3
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for nikolaos androulakis
Search for Nikolais Androulaki instead (2 results)
Prognostic Value of KRAS Mutations in Colorectal Cancer Patients.
Koulouridi A, Karagianni M, Messaritakis I, Sfakianaki M, Voutsina A, Trypaki M, Bachlitzanaki M, Koustas E, Karamouzis MV, Ntavatzikos A, Koumarianou A, Androulakis N, Mavroudis D, Tzardi M, Souglakos J. Koulouridi A, et al. Among authors: androulakis n. Cancers (Basel). 2022 Jul 7;14(14):3320. doi: 10.3390/cancers14143320. Cancers (Basel). 2022. PMID: 35884381 Free PMC article.
Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy.
Bachlitzanaki M, Aletras G, Bachlitzanaki E, Messaritakis I, Koukias S, Koulouridi A, Bachlitzanakis E, Kaloeidi E, Vakonaki E, Kontopodis E, Androulakis N, Chamilos G, Mavroudis D, Ioannou P, Kofteridis D. Bachlitzanaki M, et al. Among authors: androulakis n. Microorganisms. 2023 Oct 12;11(10):2547. doi: 10.3390/microorganisms11102547. Microorganisms. 2023. PMID: 37894205 Free PMC article.
RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer.
Koumarianou A, Ntavatzikos A, Symeonidis D, Vallilas C, Giannakakou M, Papaxoinis G, Xynogalos S, Boukovinas I, Demiri S, Kampoli K, Oikonomopoulos G, Samantas E, Res E, Androulakis N, Vourli G, Souglakos I, Karamouzis M. Koumarianou A, et al. Among authors: androulakis n. Biomedicines. 2023 Apr 24;11(5):1267. doi: 10.3390/biomedicines11051267. Biomedicines. 2023. PMID: 37238938 Free PMC article.
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
Apostolou P, Fostira F, Kouroussis C, Kalfakakou D, Delimitsou A, Agelaki S, Androulakis N, Christodoulou C, Kalbakis K, Kalykaki A, Sanidas E, Papadimitriou C, Vamvakas L, Georgoulias V, Mavroudis D, Yannoukakos D, Konstantopoulou I, Saloustros E. Apostolou P, et al. Among authors: androulakis n. Int J Cancer. 2020 Sep 1;147(5):1334-1342. doi: 10.1002/ijc.32903. Epub 2020 Mar 5. Int J Cancer. 2020. PMID: 32022259 Free article.
Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece.
Gourzoulidis G, Koulentaki M, Koumarianou A, Samadas E, Androulakis N, Xynogalos S, Papakotoulas P, Boukovinas I, Karamouzis M, Souglakos J, Chotzagiannoglou V, Beletsi A, Kourlaba G. Gourzoulidis G, et al. Among authors: androulakis n. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):259-269. doi: 10.1080/14737167.2021.1921576. Epub 2021 May 6. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 33900864
43 results